RESUMO
OBJECTIVES: Delirium is an acute neuropsychiatric condition associated with increased morbidity and mortality. There is increasing recognition of delirium as a substantial health burden in younger patients, although few studies have characterized its occurrence. This study analyzes the occurrence of delirium diagnosis, its comorbidities, and cost among youth hospitalized in the United States. METHODS: The Kids' Inpatient Database, a national all-payers sample of pediatric hospitalizations in general hospitals, was examined for the year 2019. Hospitalizations with a discharge diagnosis of delirium among patients aged 1-20 years were included in the analysis. RESULTS: Delirium was diagnosed in 43,138 hospitalizations (95% CI: 41,170-45,106), or 2.3% of studied hospitalizations. Delirium was diagnosed in a broad range of illnesses, with suicide and self-inflicted injury as the most common primary discharge diagnosis among patients with delirium. In-hospital mortality was seven times greater in hospitalizations caring a delirium diagnosis. The diagnosis of delirium was associated with an adjusted increased hospital cost of $8648 per hospitalization, or $373 million in aggregate cost. CONCLUSIONS: Based on a large national claims database, delirium was diagnosed in youth at a lower rate than expected based on prospective studies. The relative absence of delirium diagnosis in claims data may reflect underdiagnosis, a failure to code, and/or a lower rate of delirium in general hospitals compared with other settings. Further research is needed to better characterize the incidence and prevalence of delirium in young people in the hospital setting.
Assuntos
Delírio , Pacientes Internados , Criança , Humanos , Estados Unidos/epidemiologia , Adolescente , Estudos Prospectivos , Hospitalização , Comorbidade , Delírio/diagnóstico , Delírio/epidemiologiaRESUMO
Background: In recent years, there has been an increasing burden of child and adolescent mental illness recognized in the United States, and the need for pediatric mental health care is growing. Pediatric consultation-liaison (C-L) psychiatrists are increasingly playing a role in the management of medical and psychiatric disease for pediatric patients. The field is a fast-moving one, with understanding of new neuropsychiatric disease entities; reformulation of prior disease entities; and new interdisciplinary treatments and models of care. Methods: In this study, we aim to review recent advances in the field of pediatric C-L psychiatry, including new diagnostic entities, updated management of frequently encountered clinical presentations, and developments in systems of care. Conclusion: The advances in pediatric C-L psychiatry are broad and serve to promote more streamlined, evidence-based care for the vulnerable population of psychiatrically ill pediatric medical patients. More work remains to determine the most effective interventions for the wide array of presentations seen by pediatric C-L psychiatrists.
Assuntos
Atenção à Saúde/tendências , Transtornos Mentais/diagnóstico , Transtornos Mentais/patologia , Transtornos Mentais/terapia , Psiquiatria/tendências , Encaminhamento e Consulta/tendências , Criança , HumanosRESUMO
BACKGROUND: Autism spectrum disorder (ASD) is a common neurodevelopmental disorder that affects one in 40 children. Individuals with ASD have high rates of medical comorbidity, excess mortality, high health care expenditures, and difficulty accessing coordinated medical care. As the prevalence of ASD rises, consultation-liaison (C-L) psychiatrists will be increasingly called upon to assist patients with ASD both in inpatient and outpatient medical settings. METHODS: In this article, we review the patient, provider, and systems factors that converge to create challenges for delivering high-quality, patient-centered medical care for patients with ASD. CONCLUSION: Strategies to optimize the care of patients with ASD in medical settings include previsit planning, anticipating and reducing sources of distress, facilitating a patient- and family-centered multidisciplinary approach, employing environmental interventions, and using psychopharmacologic treatments.
Assuntos
Transtorno do Espectro Autista/psicologia , Transtorno do Espectro Autista/terapia , Assistência Centrada no Paciente/métodos , Psiquiatria/métodos , Encaminhamento e Consulta , HumanosRESUMO
BACKGROUND: Pediatric catatonia is believed to be a rare condition, but challenges in recognition and variability in presentation may lead to underdiagnosis. Early identification and effective treatment of pediatric catatonia is critical given the significant morbidity and mortality associated with the condition. Given the widespread shortage of child and adolescent psychiatrists, at times consultation-liaison (C-L) psychiatrists without child training may be the frontline specialty providers asked to guide treatment of these pediatric patients. OBJECTIVE: To review the literature on pediatric catatonia using clinical cases to illustrate unique aspects of its presentation, evaluation, and management. METHODS: We describe the presentation and management of 6 adolescents with catatonia on an inpatient pediatric service at a general hospital and use these cases as a focal point for a review of the literature. CONCLUSION: Pediatric catatonia is a potentially lethal disease entity that can be effectively treated if accurately identified early in its course. Psychiatrists working in a C-L setting may encounter this syndrome and should be aware of its presentation, evaluation, and management.
Assuntos
Catatonia/diagnóstico , Catatonia/terapia , Eletroconvulsoterapia/métodos , Moduladores GABAérgicos/uso terapêutico , Lorazepam/uso terapêutico , Adolescente , Catatonia/fisiopatologia , Feminino , Humanos , MasculinoAssuntos
Catatonia , Eletroconvulsoterapia , Adolescente , Benzodiazepinas , Humanos , Resultado do TratamentoAssuntos
Obstrução das Vias Respiratórias/psicologia , Apetite/fisiologia , Transtornos de Alimentação na Infância , Terapia Comportamental , Encéfalo/diagnóstico por imagem , Encéfalo/fisiologia , Criança , Diagnóstico Diferencial , Insuficiência de Crescimento , Família , Medo , Transtornos de Alimentação na Infância/diagnóstico , Transtornos de Alimentação na Infância/fisiopatologia , Transtornos de Alimentação na Infância/terapia , Feminino , Alimentos , Humanos , Imageamento por Ressonância MagnéticaAssuntos
Transtorno Bipolar/diagnóstico , Doença de Graves/psicologia , Transtornos Psicóticos/etiologia , Glândula Tireoide/patologia , Adolescente , Transtornos Psicóticos Afetivos/diagnóstico , Antipsicóticos/uso terapêutico , Antitireóideos/uso terapêutico , Benzodiazepinas/uso terapêutico , Transtorno Bipolar/tratamento farmacológico , Transtorno Bipolar/etiologia , Delírio/diagnóstico , Diagnóstico Diferencial , Feminino , Doença de Graves/tratamento farmacológico , Doença de Graves/cirurgia , Humanos , Metimazol/uso terapêutico , Olanzapina , Cintilografia , Glândula Tireoide/diagnóstico por imagem , TireoidectomiaRESUMO
OBJECTIVES: Pediatric and young adult patients frequently present to medical inpatient (MIP) units for treatment of substance use disorder (SUD). Given the risk of lifelong dependence and related complications in early life substance use (SU), a review of the literature is warranted. METHODS: We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) systematic review of literature published through April, 62,020, which examined incidence, screening, and complications of pediatric and young adult SU in the MIP setting. RESULTS: 8843 articles were screened, and 28 articles were included for final qualitative synthesis. The overall prevalence of SU-related discharge diagnoses ranged from 1.3% to 5% for patients aged 0 to 26 years. When compared to adult patients, nearly double the rate of co-morbid psychopathology was observed. Three studies utilized systematic screening tools, with the remainder relying on biologic screens and admission or discharge diagnoses. CONCLUSIONS: The results of our review indicate that current screening practices for SU in the MIP clinical setting are subpar and likely result in an underestimation of incidence and morbidity due to limited use of systematic screening tools. Despite this, incidence of SU hospitalizations and related medical and psychiatric complications continue to rise.
Assuntos
Transtornos Relacionados ao Uso de Substâncias , Adolescente , Criança , Comorbidade , Hospitalização , Humanos , Incidência , Programas de Rastreamento , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/terapia , Adulto JovemRESUMO
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder, affecting an estimated 1 in 40 children. Children with ASD have high rates of medical comorbidity and often experience high levels of distress during medical admissions, increasing the risk of agitation. Pediatric hospitalists receive minimal formal training on the inpatient care of children with ASD. In this article, we review strategies that pediatric hospitalists can use to optimize the care of children with ASD during inpatient admissions. These include gathering an ASD-related history early in the admission to understand the child's baseline core ASD symptoms, including social and communication ability, sensory needs, and restricted or repetitive behaviors. This information can be used to tailor the hospitalist's approach in each of these 3 domains. We conclude by reviewing procedure-related considerations, an approach to managing agitation, and quality improvement interventions.
Assuntos
Transtorno do Espectro Autista , Transtorno do Espectro Autista/epidemiologia , Transtorno do Espectro Autista/terapia , Criança , Comorbidade , Hospitalização , Humanos , Pacientes InternadosRESUMO
OBJECTIVES: Our goals for this study were to characterize the frequency of agitation in patients with autism spectrum disorder (ASD) admitted to an inpatient pediatric medical unit and to identify risk factors associated with agitation. METHODS: Through a retrospective chart review, we identified every patient between 8 and 19 years of age with a documented ASD diagnosis admitted to a pediatric medical unit over a 5-year period. We performed a detailed review of each admission, with a focus on factors hypothesized to be correlated with risk of agitation. RESULTS: One or more episode of agitation occurred during 37 (12.4%) of the 299 admissions and for 31 (18.5%) of the 168 patients who met inclusion criteria. History of agitation (risk ratio 21.9 [95% confidence interval 5.4-88.3] for history of severe agitation; P < .001) and documented sensory sensitivities (risk ratio 2.3 [95% confidence interval 1.3-3.8]; P < .001) were associated with a significantly increased risk of agitation during admission. History of past psychiatric admissions was associated with increased risk before, but not after, controlling for history of agitation and sensory sensitivities. Psychiatric comorbidity, intellectual disability, acute pain on admission, number of preadmission psychotropic medications, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition ASD diagnosis, age, and sex were not significantly associated with increased risk. CONCLUSIONS: Hospitalization can be challenging for patients with ASD. A subset of these patients experience episodes of agitation during admission, posing a safety risk to patients and staff. Characterizing risk factors associated with these behaviors may allow for identification of at-risk patients and guide targeted intervention to prevent negative behavioral outcomes.
Assuntos
Transtorno do Espectro Autista/complicações , Hospitalização , Agitação Psicomotora/etiologia , Adolescente , Criança , Feminino , Humanos , Masculino , Agitação Psicomotora/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Adulto JovemRESUMO
An immune-mediated subtype of autism spectrum disorder (ASD) has long been hypothesized. This article reviews evidence from family history studies of autoimmunity, immunogenetics, maternal immune activation, neuroinflammation, and systemic inflammation, which suggests immune dysfunction in ASD. Individuals with ASD have higher rates of co-morbid medical illness than the general population. Major medical co-morbidities associated with ASD are discussed by body system. Mechanisms by which FDA-approved and emerging treatments for ASD act upon the immune system are then reviewed. We conclude by proposing the hypothesis of an immune-mediated subtype of ASD which is characterized by systemic, multi-organ inflammation or immune dysregulation with shared mechanisms that drive both the behavioral and physical illnesses associated with ASD. Although gaps in evidence supporting this hypothesis remain, benefits of this conceptualization include framing future research questions that will help define a clinically meaningful subset of patients and focusing clinical interactions on early detection and treatment of high-risk medical illnesses as well as interfering behavioral signs and symptoms across the lifespan.
Assuntos
Transtorno do Espectro Autista/imunologia , Transtorno do Espectro Autista/psicologia , Encéfalo/imunologia , Transtorno do Espectro Autista/metabolismo , Encéfalo/metabolismo , Comorbidade , Humanos , Sistema Imunitário/imunologia , Sistema Imunitário/metabolismo , Inflamação/imunologia , Inflamação/metabolismo , Inflamação/psicologiaRESUMO
INTRODUCTION: Marked intolerance or intrusive re-experiencing of ordinary sensory stimuli that in turn drive functionally impairing compulsive behaviors are occasionally seen in young children with OCD. METHODS: We describe a number of children with DSM-IV OCD ascertained from a family genetic study of pediatric OCD, whose intolerance of ordinary sensory stimuli created significant subjective distress and time-consuming ritualistic behavior that was clinically impairing. RESULTS: In each case, these sensory symptoms were the primary presenting symptoms and were experienced in the absence of intrusive thoughts, images, or ideas associated with "conventional" OCD symptoms. CONCLUSIONS: These symptoms suggest abnormalities in sensory processing and integration in at least a subset of OCD patients. Recognition of these sensory symptoms and sensory-driven behaviors as part of the broad phenotypic variation in children with OCD could help clinicians more easily identify OCD patients and facilitate treatment.
Assuntos
Transtorno Obsessivo-Compulsivo/psicologia , Transtornos de Sensação/psicologia , Adolescente , Nível de Alerta , Atenção , Criança , Comorbidade , Feminino , Humanos , Masculino , Transtorno Obsessivo-Compulsivo/diagnóstico , Transtorno Obsessivo-Compulsivo/tratamento farmacológico , Determinação da Personalidade/estatística & dados numéricos , Psicometria , Fatores de Risco , Transtornos de Sensação/diagnóstico , Transtornos de Sensação/tratamento farmacológico , Filtro Sensorial , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Síndrome de Tourette/diagnóstico , Síndrome de Tourette/tratamento farmacológico , Síndrome de Tourette/psicologiaRESUMO
Cancer in adolescents is uncommon and when it occurs raises a number of unique challenges for both the patient and their families. Adolescence is a period of time of significant physical and emotional changes and a diagnosis of cancer during this time has a major impact on their psychological and physical development. In this review we will look at the psychosocial issues facing adolescents who have cancer. We will address adolescent development, issues related to informed consent and assent, initial responses to the diagnosis of cancer, quality of life and the experience of the adolescent with cancer, psychological adjustment, support systems, body image issues, sexuality, education, hope, and treatment compliance.
Assuntos
Desenvolvimento do Adolescente/fisiologia , Neoplasias/psicologia , Psicologia do Adolescente/métodos , Adolescente , Humanos , Consentimento Livre e Esclarecido/psicologiaRESUMO
The aim of this review is to summarize the recent literature regarding abnormalities in sensory functioning in individuals with autism spectrum disorder (ASD), including evidence regarding the neurobiological basis of these symptoms, their clinical correlates, and their treatment. Abnormalities in responses to sensory stimuli are highly prevalent in individuals with ASD. The underlying neurobiology of these symptoms is unclear, but several theories have been proposed linking possible etiologies of sensory dysfunction with known abnormalities in brain structure and function that are associated with ASD. In addition to the distress that sensory symptoms can cause patients and caregivers, these phenomena have been correlated with several other problematic symptoms and behaviors associated with ASD, including restrictive and repetitive behavior, self-injurious behavior, anxiety, inattention, and gastrointestinal complaints. It is unclear whether these correlations are causative in nature or whether they are due to shared underlying pathophysiology. The best-known treatments for sensory symptoms in ASD involve a program of occupational therapy that is specifically tailored to the needs of the individual and that may include sensory integration therapy, a sensory diet, and environmental modifications. While some empirical evidence supports these treatments, more research is needed to evaluate their efficacy, and other means of alleviating these symptoms, including possible psychopharmacological interventions, need to be explored. Additional research into the sensory symptoms associated with ASD has the potential to shed more light on the nature and pathophysiology of these disorders and to open new avenues of effective treatments.